You Can Make a Difference!
The Collaborative Group of the Americas on Inherited Gastrointestinal Cancers (CGA-IGC) is a premiere professional society dedicated to forwarding clinical care for individuals and their family members with hereditary, familial and early-age onset gastrointestinal cancers through research, education, and patient advocacy.
Patients and families benefit greatly from scientific advances in cancer prevention, early detection, and personalized treatment.
Your gift to CGA–IGC will go directly to supporting our efforts to be a resource for individuals and institutions working to ELIMINATE hereditary, familial and early-age onset GI cancers.
Make a Donation to CGA-IGC Here
CGA-IGC is a tax-exempt organization under Section 501(c)(3) of the Internal Revenue Code ([EIN 90-0843053]). All gifts to CGA-IGC are tax deductible to the full extent of the law. No goods or services were given in consideration for this contribution unless expressly noted0843053]).
All gifts to CGA-IGC are tax deductible to the full extent of the law. No goods or services were given in consideration for this contribution unless expressly noted.
The CGA-IGC leadership is grateful for your contribution to support its mission of improving the lives of those with hereditary cancer syndromes through:
Education – offering continuing-education accredited webinars, podcasts and journal scans to physicians, scientists and allied healthcare professionals, ensuring the multidisciplinary workforce is equipped with the knowledge and resources needed to care for patients and their families’.
Research – advancing science through our annual research grant open to early-career professionals addressing any component of CGA-IGC’s mission and access resources for developing new hereditary registries and supporting their registries.
Advocacy – fostering collaborations with advocacy partners and raising awareness of hereditary GI cancers and best clinical & research practices.
Capacity Building – providing mentoring support to trainees, early career professionals and emerging leaders in our field so that they can build a brighter future for those affected by hereditary GI cancers.